International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN. 

Simultaneous Estimation of S-RRR Nebivolol and R-SSS Nebivolol in Human Plasma by Using Liquid Chromatography-tandem Mass Spectrometry

    , , ,

Author Affiliations

  • 1Bioanalytical Research Department, Synergen Bio pvt. Ltd. Pune, Maharashtra, India
  • 2Bioanalytical Research Department, Synergen Bio pvt. Ltd. Pune, Maharashtra, India
  • 3Bioanalytical Research Department, Synergen Bio pvt. Ltd. Pune, Maharashtra, India
  • 4Bioanalytical Research Department, Synergen Bio pvt. Ltd. Pune, Maharashtra, India

Res. J. of Pharmaceutical Sci., Volume 14, Issue (2), Pages 1-13, December,30 (2025)

Abstract

The present study describes a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous estimation of S-RRR and R-SSS nebivolol in human plasma using solid phase extraction technique. Method of both S-RRR and R-SSS nebivolol has been developed, validated by using S-RRR nebivolol D4 and R-SSS nebivolol D4 as an internal standard. Analytes from human plasma were extracted by ion exchange cartridges and subsequently separated on chiral column using acetonitrile: 1.5 mM ammonium carbonate in water, 70:30% v/v as a mobile phase, at a flow rate of 1.0 ml min-1. Quantification of S- RRR and R-SSS nebivolol and nebivolol D4 was performed using multi-reaction monitoring mode (MRM) in positive mode. The calibration curve was linear (r2 > 0.99) over the concentration range of 20.0-20000.0 pg ml for S-RRR and R-SSS nebivolol. The intra-day and inter-day assay precision revealed within ±15% (at LLOQ level ±20%) with accuracy within 85-115% (at LLOQ level 80-120%). The LC-MS/MS method was fully validated for all the validation parameters as per M10 and current regulatory requirement such as selectivity, matrix effect, recovery and stability. Overall the present study revealed the selectivity and sensitivity of this method for the simultaneous estimation of S-RRR and R-SSS nebivolol in human plasma.

References

  1. Sahana, G. N., Sarala, N., & Kumar, T. N. (2011)., Nebivolol-pharmacological aspects.,
  2. Howlett, J. G. (2014)., Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease., Canadian Journal of Cardiology, 30(5), S29-S37.
  3. Ang, S. F., Moochhala, S. M., Bhatia, M., Bauer, C. C., Boyle, J. P., Porter, K. E., ... & Vellecco, V. (2010)., Pathophysiology of hypertension., Transplantation, 159, 451-455.
  4. Ramakrishna, N. V. S., Vishwottam, K. N., Puran, S., Koteshwara, M., Manoj, S., & Santosh, M. (2004)., Selective and rapid liquid chromatography–tandem mass spectrometry assay of dutasteride in human plasma., Journal of Chromatography B, 809(1), 117-124.
  5. Nandania, J., Rajput, S. J., Contractor, P., Vasava, P., Solanki, B., & Vohra, M. (2013)., Quantitative determination of nebivolol from human plasma using liquid chromatography–tandem mass spectrometry., Journal of Chromatography B, 923, 110-119.
  6. Neves, D. V., Vieira, C. P., Coelho, E. B., Marques, M. P., & Lanchote, V. L. (2013)., Stereoselective analysis of nebivolol isomers in human plasma by high-performance liquid chromatography–tandem mass spectrometry: application in pharmacokinetics., Journal of Chromatography B, 940, 47-52.
  7. Thevis, M., & Schänzer, W. (2005)., Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: Ephedrines, β-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins., Journal of chromatographic science, 43(1), 22-31.
  8. Kachhadia, P. K., Doshi, A. S., & Joshi, H. S. (2008)., Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation., Journal of AOAC International, 91(3), 557-561.
  9. Hendrickx, J., Bockx, M., Zwijsen, C., Borgmans, C., Mannens, G., Meuldermans, W., & Heykants, J. (1996)., Location of the hydroxyl functions in hydroxylated metabolites of nebivolol in different animal species and human subjects as determined by on-line high-performance liquid chromatography-diode-array detection., Journal of chromatography. A, 729(1-2), 341-354.
  10. European Medicines Agency (2011)., Committee for medicinal products for human use: guideline on bioanalytical method validation.,
  11. Wagil, M., Maszkowska, J., Białk-Bielińska, A., Caban, M., Stepnowski, P., & Kumirska, J. (2015)., Determination of metronidazole residues in water, sediment and fish tissue samples., Chemosphere, 119, S28-S34.
  12. Younes, A. A., Mangelings, D., & Vander Heyden, Y. (2012)., Chiral separations in reversed-phase liquid chromatography: evaluation of several polysaccharide-based chiral stationary phases for a separation strategy update., Journal of Chromatography A, 1269, 154-167.
  13. Tachibana, K., & Ohnishi, A. (2001)., Reversed-phase liquid chromatographic separation of enantiomers on polysaccharide type chiral stationary phases., Journal of Chromatography a, 906(1-2), 127-154.
  14. Chankvetadze, B. (2012)., Enantioseparations by high-performance liquid chromatography using polysaccharide-based chiral stationary phases: an overview., Chiral Separations: Methods and Protocols, 81-111.